Metabolic Syndrome, Cardiovascular Disease, and the Hair Growth Cycle: Addressing Hair Growth Disruptions Using Nourkrin with Marilex as a Proteoglycan Replacement Therapy: A Concise Review

    May 2018
    Erling Thom, Jan Wadstein, Kingsley Dh, Thom Ew
    Image of study
    TLDR Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.
    The review from May 22, 2018, explored the link between metabolic syndrome, cardiovascular disease, and hair growth disruptions, particularly androgenetic alopecia (AGA). It found that alopecia is associated with an increased risk of coronary heart disease, hypertension, hyperinsulinemia, insulin resistance, and metabolic syndrome, with the severity of alopecia correlating with the risk of coronary heart disease. However, the relationship between AGA and metabolic syndrome was not definitively established. The authors suggested that AGA could be an early marker of metabolic syndrome and recommended early screenings and lifestyle changes to reduce associated risks. The review also reported on the effectiveness of Nourkrin® with Marilex®, a proteoglycan replacement therapy, in promoting hair growth. A double-blind placebo-controlled trial showed a 35.7% increase in hair count over 6 months, indicating the therapy's significant effect on hair growth.
    Discuss this study in the Community →

    Research cited in this study

    24 / 24 results

    Related Community Posts Join

    6 / 1000+ results

      community 4600 - result 9 month - Dr. Carman

      in Progress Pictures  255 upvotes 9 months ago
      A user shared their 9-month post-hair transplant results with 4600 grafts, using only Nourkin hair vitamins, Vitamin D, and B12, and expressed satisfaction. The replies debated the necessity of medications like finasteride and minoxidil for maintaining hair health.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Similar Research

    5 / 1000+ results